Markets | |
It's been amazing to witness the way that technology has changed how businesses operate over the last decade. With new data storage capabilities that can dramatically improve the efficiency of how companies function, most businesses are quickly making the move to the cloud. Major corporations are ... Read the Full Story |
|
From Our Partners | | On May 21, 2026, a federal bank board unanimously approved a nearly $3 billion loan to build a gold mine on American soil. Congress had 25 days notice and raised no objections.
The company's own filings cite substantial support and partnership from the Department of War. Alongside gold, the deposit holds a second metal China has banned from export to the U.S., the only domestic reserve of its kind.
The company is roughly one fiftieth the size of Newmont. | | Get the name and ticker before the signature is finalized |
|
Markets | |
Finding good stocks to buy in the market these days is no easy task. Although stocks have rebounded nicely off of the March lows, many investors are having trouble figuring out why. Some even believe that we have never seen such a large disconnect between equity valuations and fundamentals. Even b... Read the Full Story |
|
Markets | |
Latin America is a region of the world that seems to be a little late to the party in terms of adapting e-commerce into their everyday life. However, that seems to be changing fast thanks to MercadoLibre (NASDAQ:MELI), which is a rapidly growing online commerce and payments business. The company r... Read the Full Story |
|
From Our Partners | | A new tool called Oracle tracks insider bets hidden in the predictions market, flagging which stocks and options could be affected.
During beta testing, Oracle identified notable short-term moves including USO up 39% in four days, PLTR up 43% in a day, and WEN up 67% in two days, all through a regular brokerage account.
See how Oracle spots these hidden insider bets before they make headlines. | | Get free access to Oracle and see the data now |
|
Markets | |
On Friday, May 8 Kimco Realty (NYSE:KIM) posted a positive first-quarter earnings report. For a real estate investment trust (REIT), the quarterly funds from operation (FFO) is a critical metric. And Kimco delivered FFO of 37 cents per share. This beat analysts’ estimates for 36 cents per sh... Read the Full Story |
|
Markets | |
As volatile as the stock market has been for the last couple of months now, the cryptocurrency market has been that volatile for years now. Bitcoin, pretty much the gold standard in cryptocurrency, has seen wild changes in valuation just in the last year. The price over the last year retested the ... Read the Full Story |
|
From Our Partners | | The Buffett Indicator once flagged the 1929, 1969, and 2000 market peaks - and it's now at 231%, its highest reading in history.
Gold analyst Garrett Goggin, CFA, CMT, has tracked this signal for years and says the pattern points to money rotating from overpriced tech into gold.
Porter Stansberry has called Goggin the most knowledgeable gold investor in the world. | | See Garrett Goggin's four top gold mining picks now |
|
Markets | | Clorox Is The #1 Bet For Pandemic-Driven Gains
Clorox (CLX) reported earnings for the first quarter last week and gave what I called then a “goldilocks report”. The headline figures were above consensus, they showed growth from the previous year, and were backed up by internal data that... Read the Full Story |
|
Markets | | Despite their shares taking a heavy beating with the rest of the equity market in March, over the past few weeks Peloton (NASDAQ: PTON) has joined the ranks of stocks that ended up hitting fresh all time highs in the face of the coronavirus pandemic. In light of many non-essential businesses shuttin... Read the Full Story |
|
Technology | |
In recent years, watching Apple (NASDAQ: AAPL) acquire company after company has been something of a pastime for the tech field. Between that and watching what comes out of the Apple patent mill, it's been a great way to get a better idea of where the company's going and what it might be planning... Read the Full Story |
|
Markets | | Consumer Staples, It’s What You Want To Own
The consumer staples (XLP) stocks have been on a tear and no wonder. The global coronavirus pandemic is driving people to stay home, stock up, and social-distance, and that means big spending in the staples categories. Companies like Conagra (CAG), ... Read the Full Story |
|
Markets | |
This week is sure to be one of the most important weeks of the year thus far for the stock market. With tons of major companies reporting their earnings, all eyes are on the FAANG stocks. Massive companies like Amazon, Microsoft, and Google make up a big portion of the major indices like the S&... Read the Full Story |
|
The Early Bird Stock Of The Day VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited; and the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts. | | View Today's Stock Pick |
|
